Kenya’s livestock industry is an important source of livelihood for many people in the Arid and Semi-Arid Lands (ASAL) and the high potential areas. The industry contributes significantly to Kenya’s economic development accounting for 10% of the country’s Gross Domestic Product (GDP).
The 2008 population and housing census revealed that Kenya has a massive livestock resource comprising of 3.4 million exotic cattle, 14.1 million indigenous cattle, 17.1 million sheep, 27.7 million goats, 2.9 million camels 25.8 indigenous chicken, and 6.1 million exotic chicken.
This is an important resource that if tapped could create more wealth and employment in the country thereby contributing significantly to poverty reduction, and pushing Vision 2030 forward.
The Kenya Veterinary Vaccine Production Institute (KEVEVAPI) is aware of the need to protect this important resource. As the country gears up towards the realization of the goals of the Kenya Vision 2030, many challenges are bound to arise, key among them being the outbreak of livestock diseases.
The Vision has identified the creation of Disease Free Zones (DFZ) as one of the flagship projects whose main objective is to ensure the production of clean animals that could comfortably trade in the international markets. KEVEVAPI, therefore, has a great role to play in the production and marketing of high quality vaccines to protect our livestock.